The present report examines the roles of suppressor cells during host-tumor interaction in which the tumor is rejected, as well as that during a progressively growing lesion in an unresponsive mouse strain. Using a spontaneously derived AKR/J carcinoma-like tumor,1 differential growth patterns were observed in the parental AKR/J, as compared to (AKR/J × DBA/2)F1 and (AKR/J × C57BL/ 6)F1 hybrids. This study demonstrates that depression of immune responsiveness and the generation of suppressor cells, appears to correlate with the strength or weakness of the specific anti-tumor responses in these strains of mice.
Materials and Methods
Mice. 6-to 8-wk-old male AKR/J, (AKR/J × DBA/2)F~, and (AKR/J x C57BL/6)F~ were purchased from The Jackson Laboratory, Bar Harbor, Maine, and housed in animal rooms at the Immunology Branch, NIH, Bethesda, Md.
Tumors. All animals were injected subcutaneously with 5 × 10 e AKR/J carcinoma-like tumor cells ~ in Hanks' balanced salt solution at a total vol of 0.25 ml. At 10-12 days postinjection, the size of the tumors in the AKR/J and AKB6F~ were approximately equal (10-12 mm diameter), while that in the AKD2F~ was somewhat larger (15-18 mm).
In Vitro Generation of Antibody Responses. Responding spleen cells were cultured for 3 or 4 days with trinitrophenyl-lipopolysaccharide (TNP-LPS) or sheep erythrocytes (SRBC), respectively, in 96-well flat bottom Microtest II plates (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.). Specific plaque-forming cells (PFC) per 10 7 cultured spleen cells were measured as previously described. 2
In Vitro Generation of Cytotoxic Responses. Responding spleen cells were incubated with irradiated (10,000 rads) syngeneic AKR/J tumor cells or 2,000 rads irradiated allogeneic spleen cells as described elsewhere. 2 After 5 days of incubation, effector cells were harvested and assayed for specific cell-mediated cytotoxicity.
Cytotoxic Assay. Target cells, L5MF-22 (H-2 b) lymphoma, PS15-Y (H-2 ~) mastocytoma, and AKR/J (H-2 k) carcinoma-like cells were labeled with 51Cr and incubated at 37°C in 5% CO2 with effector cells for 4-5 h as described elsewhere2 The percentage specific release of 51Cr was calculated as follows:
experimental cpm -control cpm × 100. total cpm freeze-thaw -background cpm Results and Discussion Spleen cells from AKR/J, AKD2F1, and AKB6F1 mice were sensitized in vitro against AKR/J tumor cells. The results in Table I show that AKB6F1 and AKR/J, but not AKD2F, spleen cells were able to generate specific anti-tumor effector cells. The secondary cell-mediated anti-tumor responses, in which spleen cells from mice preimmunized with 5 x 10 6 viable tumor cells were sensitized against the same tumor in culture, showed similar results. 3 These in vitro findings correlated with the in vivo growth pattern of the tumor in these strains. Thus, the ADK2F1 hybrid, which did not reject the tumor in vivo, also appears to be unable to respond effectively against the tumor in vitro. The AKR/J and AKB6F1 animals, which generated a successful anti-tumor response in vivo, were also capable of effecting a significant cell-mediated antitumor response in vitro. Thus, the H-2 d allele appeared to be associated with susceptibility, whereas the H-2 k and H-2 b alleles were associated with resistance. It is noteworthy that the strongest anti-tumor responses were associated with the H-2 b allele, 3 which has previously been found to be associated with strong resistance to murineleukemia virus-induced neoplasms (7) .
The data in Table II illustrate that the splenic lymphocytes of tumor-bearing (12 day) AKR/J and AKD2F~ mice were markedly depressed in their ability to generate allogeneic effector cells after a primary in vitro sensitization against the relevant antigens. In contrast, the AKB6F1 spleen cells did not demonstrate any depression in their ability to elicit such a response. Mixtures of spleen cells from tumor-bearing mice of all three strains with normal syngeneic spleen cells failed to demonstrate any "true" suppressive activity, i.e., the decreased level of response in these cultures could be accounted for by a dilution effect of the unresponsive population (Table II) . We have also found that depression of mixed lymphocyte and mitogen reactivity follows a similar pattern in these strains. 4 Thus, the cellular immune reactivity in 12-day posttumor injected AKR/J, as well as the unresponsive AKD2F1 mice was found to be markedly depressed, but suppressive activity, capable of inhibiting these responses by normal populations, was not demonstrable. Similar to the depression observed in the aforementioned responses, we also found (Fig. 1 A) that AKR/J and ADK2F~ spleen cells from 12-day tumorbearing hosts were strikingly deficient in their ability to generate direct PFC's to both T-dependent (SRBC) and T-independent (TNP-LPS) antigens after primary in vitro sensitization. The highly responsive AKB6FI strain again displayed no depression in its ability to produce PFC's to either of the two immunogens. When spleen cells from the AKR/J and ADK2F1 animals were mixed with their respective syngeneic normal spleen populations (Fig. 1 B) , the direct PFC responses of these cultures to both SRBC and TNP-LPS were suppressed to levels similar to that of the unresponsive spleen cells. Therefore, unlike the cell-mediated response to allogeneic spleen cells, antibody responses elicited by spleen cells from normal mice could be suppressed by spleen cells from tumor-bearing AKR/J and AKD2F, hosts.
There are several interpretations which could explain the finding that antibody responses, but not cell-mediated sensitization, could be suppressed by spleen cells from tumor-bearing AKR/J and AKD2F1 mice. The suppressor population generated could be specific for antibody-forming cell precursors or helpers, but not effector cell precursor populations. Although suppressor cells in other systems (5, 6) have been reported to inhibit both types of responses, it was not conclusively determined whether a single population was responsible. The suppression of antibody production in tumor-bearing AKR/J mice could prevent the accumulation of blocking factors (8), thereby increasing the effect of the host's cell-mediated rejection processes. A second explanation could be attributable to a difference in the susceptibility to suppression of the two types of responses. This could mean that a qualitatively single population of suppressors is capable of suppressing both antibody-and cell-mediated responses, but that the latter becomes susceptible only when significant levels of these cells are generated. We have recently found 4 that in the unresponsive AKD2F1 strain, suppressor cells which inhibit primary sensitizations of normal syngeneic spleen cells against alloantigens appeared during a period of tumor growth after that when cells able to suppress antibody responses were demonstrable. Cantor et al. have recently shown that the generation of suppressive activity in response to erythrocyte antigens is directly proportional to the amount of immunizing antigen (3) . Helper activity of spleen cells from hyperimmune animals was drastically lower than that of similar cells from optimally immu-nized mice (4) . The level of antibody response may therefore depend on the porportion of T-helper and T-suppressor cells produced. Thus, a shift in favor of the latter, for example, might result in a state of overall unresponsiveness. Kapp et al. (1) and Benacerraf et al. (2) have shown that suppressor, but not helper, cells are generated to synthetic antigens in genetic nonresponder mice. Thus, these systems of antibody responses to antigen demonstrate that the generation of helper and/or suppressor cells depends upon both the dosage of antigen, as well as the genetic capability of the responding population. The same factors appear to be critical in the interaction of the host with tumor. After tumor injection, a highly responsive strain (AKB6F1) may develop only effector mechanisms, with a minimal, if any, degree of suppression. This would result in a successful (i.e., rejection) response. A less responsive strain (AKR/J), subjected to the identical tumor dose, may generate a greater degree of suppressive activity, and therefore approach the critical equilibrium between positive and negative factors which determines the overall success or failure of the response. An unresponsive strain (AKD2F~) may selectively produce only suppressors, resulting in progressive tumor growth. It is noteworthy that the number and/or strength of these cells were found to increase as the tumor developed in the AKD2F1 animals. Thus, it is possible that this strain is genetically incapable of generating effector cells in response to the tumor examined.
Such a schema would also suggest that all responders could be subjected to some critical tumor dosage, large enough to induce numbers of suppressors able to shift the equilibrium to a state resulting in irreversible tumor growth. This is analogous to the finding that large doses of immunizing antigen lead to the generation of suppressor cells responsible for the ensuing lack of specific antibody production (4). Such a critical dosage would vary for each tumor within each strain, and would decrease as the genetic capability of the responding host decreased. Maintaining the integrity of the organism by successful rejection of tumor may, therefore, depend on: (a) the genetic capabilities of the host, i.e. immune response genes which may control anti-tumor responses, as well as (b) the tumor burden, dependent on the site of growth and the proliferative capacity of the neoplasm.
Summary
Parental AKR/J, and AKB6F1 and AKD2F~ hybrid mice were injected subcutaneously with a spontaneously arising AKR/J tumor. The highly responsive AKB6F~ strain never exhibited any depression of immune functioning during the course of tumor growth and regression. The (AKR/J) intermediately responsive strain, while able to generate a successful anti-tumor response, did display a transient reduction of immunological capability, but only during the period of tumor growth and not during tumor regression. Cells able to suppress antibody, but not cell-mediated responses, were found. The unresponsive AKD2F~ strain was characterized by both a marked depression of immune responsiveness, as well as the generation of suppressor cells to both antibody, and later, cell-mediated responses. Depression of immune responsiveness, and the generation of suppressor cells, appeared to correlate with the strength or weakness of the anti-tumor response in these strains of mice.
